Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Complex versus simple N-nitrosamines: Comprehensive genotoxicity and in silico carcinogenicity assessment toward future testing paradigms.
Journal: Science advances
Published: May 27, 2026
Studies addressing potential bioactivation and genotoxicity liabilities of the N-nitroso derivative of the antidepressant paroxetine.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: November 06, 2025
Nitrosamine Ames Data Review and Method Development: proceedings of a US FDA/HESI workshop.
Journal: Mutagenesis
Published: September 11, 2025
HESI GTTC ring trial: Concordance between Ames and rodent carcinogenicity outcomes for N-nitrosamines (NAs) with rat and hamster metabolic conditions.
Journal: Regulatory toxicology and pharmacology : RTP
Published: February 20, 2025
Re-Evaluating Acceptable Intake: A Comparative Study of N-Nitrosomorpholine and N-Nitroso Reboxetine Potency.
Journal: Environmental and molecular mutagenesis
Published: January 08, 2025
A comparative analysis of select P450 enzymes in uninduced and PB/BNF-induced hamster and rat liver S9.
Journal: Mutation research. Genetic toxicology and environmental mutagenesis
Published: December 24, 2024
Evaluation of the nitrosamine impurities of ACE inhibitors using computational, in vitro, and in vivo methods demonstrate no genotoxic potential.
Journal: Environmental and molecular mutagenesis
Published: June 28, 2024
Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines.
Journal: Regulatory toxicology and pharmacology : RTP
Published: May 12, 2022
Reproductive and developmental safety of nirmatrelvir (PF-07321332), an oral SARS-CoV-2 Mpro inhibitor in animal models.
Journal: Reproductive toxicology (Elmsford, N.Y.)
Published: December 20, 2021
Evidence reversals in primary care research: a study of randomized controlled trials.
Journal: Family practice
Published: September 23, 2021
Experiments in the EpiDerm 3D Skin In Vitro Model and Minipigs In Vivo Indicate Comparatively Lower In Vivo Skin Sensitivity of Topically Applied Aneugenic Compounds.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: January 22, 2021
Galcanezumab (Emgality) for Migraine and Cluster Headaches.
Journal: American family physician
Published: April 16, 2020
Last Updated: 09/26/2026